Study guide
Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir)
EBP-EAP Examination in Paediatrics Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding
EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)
2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity
Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol
3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections
Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening
4 Chapter 4: Acute Paediatric Emergencies & Critical Care
EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination
5 Chapter 5: Paediatric Respiratory Medicine
Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations
6 Chapter 6: Paediatric Cardiology
Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever
7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition
Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure
8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance
Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management
9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism
Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)
10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health
Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy
11 Chapter 11: Paediatric Haematology & Oncology
Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia
12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy
Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules
13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions
The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia
14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics
Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics
15 Chapter 15: Paediatric Ophthalmology & ENT Disorders
Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions
16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health
Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance
17 Chapter 17: Adolescent Medicine & Healthcare Transition
Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition
18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics
Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics
19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine
Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy
Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir)
Key Takeaways Explain This Topic AI
Suspected bacterial meningitis requires immediate IV antibiotics: cefotaxime plus ampicillin in neonates; ceftriaxone or cefotaxime in older children, with additional coverage guided by risk and local resistance. Do not delay treatment for lumbar puncture or imaging.
Absolute contraindications to immediate lumbar puncture include clinical signs of significantly raised intracranial pressure (papilledema, focal neurological deficits, Cushing's triad, GCS ≤9 or progressive deterioration in consciousness), hemodynamic shock, evolving purpura or coagulopathy/DIC, severe respiratory compromise, and infection at the puncture site.
Adjuvant dexamethasone (0.15 mg/kg IV every 6 hours) is used for suspected bacterial meningitis beyond the neonatal period; continue for 4 days for Hib or pneumococcus. Give it before or with antibiotics when possible. It is not routine treatment for meningococcal sepsis.
Typical CSF patterns support diagnosis: bacterial meningitis often causes turbid CSF, neutrophilic pleocytosis, high protein and low glucose; viral infection often causes lymphocytes and normal glucose. Patterns overlap, so interpret them with the clinical presentation and microbiological tests.
HSV encephalitis causes fever, altered consciousness, focal seizures and behavioral change. Start IV aciclovir immediately pending CSF PCR: 20 mg/kg every 8 hours in young infants, 500 mg/m2 every 8 hours at 3 months–12 years, and 10 mg/kg every 8 hours above 12 years; adjust for renal function.
Last updated: November 2026
Pediatric CNS Infections: Meningitis and Encephalitis
Central nervous system infections represent some of the most critical medical emergencies in pediatrics. Acute bacterial meningitis carries a mortality rate of 5% to 10% in developed nations and inflicts permanent neurodevelopmental sequelae—including sensorineural hearing loss, motor deficits, epilepsy, and intellectual disability —in up to 20% to 30% of survivors. Rapid recognition, immediate initiation of bactericidal antimicrobials, adherence to lumbar puncture safety rules, and prompt administration of adjuvant therapy are paramount.
Etiology Categorized Strictly by Age Group
The microbial pathogens causing acute bacterial meningitis vary dramatically by patient age, reflecting immune system maturation and maternal antibody transfer.
1. Neonates (<1 Month / <28 Days)
Group B Streptococcus ( Streptococcus agalactiae ): The most common pathogen overall (causing ~50% of neonatal cases). Acquired vertically during delivery (early-onset) or postnatally (late-onset).
Gram-Negative Enteric Bacilli: Predominantly Escherichia coli (especially strains expressing the K1 capsular antigen , which facilitates blood-brain barrier invasion), Klebsiella pneumoniae , and Enterobacter species.
Listeria monocytogenes : Transmitted transplacentally or through maternal ingestion of unpasteurized dairy. Intrinsically resistant to all cephalosporins.
2. Infants and Children (>1 Month to 18 Years)
Neisseria meningitidis (Meningococcus): Serogroups B, C, W-135, and Y . In Europe, serogroup B accounts for the majority of pediatric cases following widespread immunization against serogroup C. Characterized by rapid progression to septic shock, purpura fulminans, and disseminated intravascular coagulation (DIC).
Streptococcus pneumoniae (Pneumococcus): A major cause of bacterial meningitis in vaccinated older infants and children. Associated with the highest mortality rate (~8–10%) and the highest rate of permanent sensorineural hearing loss (up to 30%).
Haemophilus influenzae type b (Hib): Markedly reduced across Europe by routine conjugate vaccination; remains an important cause in unvaccinated, incompletely vaccinated, or immigrant populations.
Clinical Manifestations: Neonates vs. Older Children
Recognizing meningitis requires an understanding of age-specific presentations. Young infants rarely display classic meningeal signs. +---------------------------------------------------------------------------------------------------------+
- | AGE-SPECIFIC PRESENTATIONS OF MENINGITIS |
- +---------------------------------------------------+-----------------------------------------------------+
- | Neonates & Young Infants (<12-18 Months) | Older Children & Adolescents (>18 Months) |
- +---------------------------------------------------+-----------------------------------------------------+
- | - Temperature instability (fever or hypothermia) | - Classical triad: High fever, headache, stiff neck |
- | - Lethargy, stupor, poor suck, weak feeding | - Photophobia, phonophobia, nausea, vomiting |
- | - "Paradoxical irritability" (cries when held) | - Positive Kernig's and Brudzinski's signs |
- | - Tense, bulging, or full anterior fontanelle | - Confusion, delirium, obtundation, coma |
- | - High-pitched cry, apnea, seizures | - Petechial / purpuric non-blanching rash (Meningo) |
- | - Neck stiffness and Kernig/Brudzinski ABSENT! | - Focal neurological deficits or cranial palsies |
- +---------------------------------------------------+-----------------------------------------------------+
- Clinical Examination Signs of Meningeal Irritation
Nuchal Rigidity: Inability to flex the neck forward passively to touch the chin to the chest due to painful spasm of the extensor paraspinal muscles.
Kernig's Sign: With the patient supine and the hip flexed at 90°, passive extension of the knee elicits severe pain and resistance beyond 135°.
Brudzinski's Sign: Passive flexion of the patient's neck causes involuntary, spontaneous flexion of the hips and knees.
"Paradoxical Irritability": While a normal irritable infant is comforted by parental rocking and cuddling, an infant with meningitis cries more violently when held because moving the spine stretches inflamed meninges.
Non-Blanching Rash: Petechial (<2 mm) and ecchymotic/purpuric (>2 mm) lesions that do not blanch under pressure from a clear drinking glass ( glass tumbler test ) indicate acute meningococcal septicemia and mandate immediate emergency resuscitation.
Emergency Resuscitation and Lumbar Puncture Safety
Caution
THE GOLDEN RULE OF MENINGITIS MANAGEMENT: ANTIBIOTIC THERAPY MUST NEVER BE DELAYED FOR A LUMBAR PUNCTURE OR HEAD CT SCAN! If acute bacterial meningitis is suspected, obtain blood cultures, check blood glucose, and administer immediate intravenous bactericidal antibiotics. If performing a lumbar puncture would cause delay or is contraindicated, administer antibiotics immediately; diagnostic lumbar puncture can be performed safely later once the patient is stabilized. [Suspected Acute Bacterial Meningitis]
- |
- [ABCDE Assessment & Blood Cultures Taken]
- |
- +----------------------+----------------------+
- | |
- [ABSOLUTE CONTRAINDICATION TO LP?] [NO CONTRAINDICATIONS TO LP]
- | |
- YES NO
- | |
- DO NOT PERFORM LP! - Perform LP immediately
- Give age-appropriate IV antibiotics - Give age-appropriate IV antibiotics
- Resuscitate shock / Stabilize airway - Send CSF for microscopy, biochemistry, PCR
- Neuroimaging when indicated, after stabilization - Target antibiotics to gram stain/culture
- Absolute Contraindications to Immediate Lumbar Puncture
Performing a lumbar puncture in an unstable patient or in the presence of an intracranial mass / significant cerebral edema creates a pressure gradient that drives brain parenchyma downward, precipitating fatal cerebellar tonsillar or transtentorial herniation (coning) .
Signs of Significantly Raised Intracranial Pressure:
Papilledema on funduscopy.
Severely depressed or deteriorating consciousness (NICE NG240: GCS ≤9 , or a progressive/sustained or rapid fall in consciousness).
Focal neurological deficits (e.g., hemiparesis, unilateral pupillary dilation, facial asymmetry).
Abnormal posturing (decorticate or decerebrate rigidity).
Cushing's triad (hypertension, bradycardia, irregular breathing).
Hemodynamic Instability or Septic Shock: Capillary refill time >3 seconds, hypotension, cool/mottled peripheries, or severe tachycardia. Forcing an infant into the hyperflexed spinal position further compromises venous return and precipitously worsens cardiovascular collapse.
Severe Coagulopathy or Bleeding Diathesis: Thrombocytopenia (platelets <50,000/microL ), rapidly evolving purpuric rash / DIC, or ongoing therapeutic anticoagulation. Puncture can lacerate epidural venous plexuses, causing a compressive spinal epidural hematoma and irreversible paraplegia.
Severe Respiratory Insufficiency: Respiratory distress, apnea, or impending respiratory arrest (spinal flexion occludes upper airways in young infants).
Local Cutaneous Infection: Active cellulitis, furunculosis, or sepsis over the proposed lumbar puncture site (L3–L4 or L4–L5), which would seed bacteria directly into the subarachnoid space.
- Empirical Antibiotic Regimens and Adjuvant Dexamethasone
- Empirical Antibiotic Regimens by Age
Age Bracket Empirical Antibiotic Regimen Rationale & Clinical Pearls
Neonates (<1 month) IV Ampicillin (50 mg/kg q6–8h) PLUS IV Cefotaxime (50 mg/kg q6–8h) Ampicillin covers Listeria monocytogenes and enterococci; Cefotaxime covers GBS and Gram-negative bacilli ( E. coli ). Avoid ceftriaxone in neonates (displaces bilirubin from albumin causing kernicterus, and forms biliary/urinary calcium precipitates)
Infants & Children (>1 month to 18 years) IV Ceftriaxone (80–100 mg/kg/day once daily or divided q12h, max 4 g/day) OR IV Cefotaxime (50–75 mg/kg q6h, max 12 g/day) Provides excellent, rapid bactericidal penetration across inflamed meninges against N. meningitidis , S. pneumoniae , and H. influenzae . Ceftriaxone's prolonged exposure permits once-daily dosing
Penicillin-Resistant Pneumococcus Suspected Add IV Vancomycin (15 mg/kg q6h) to Ceftriaxone/Cefotaxime Indicated in regions with high prevalence of cephalosporin-resistant S. pneumoniae or following recent travel to endemic regions
Immunocompromised Host Add IV Ampicillin to broad-spectrum cephalosporin Restores coverage against Listeria monocytogenes in patients with impaired cell-mediated immunity
Adjuvant Dexamethasone Protocol
Eligibility, Dose and Duration: For suspected bacterial meningitis beyond the neonatal period, 0.15 mg/kg IV every 6 hours ; NICE advises specialist discussion at 28 days to 3 months. Continue for 4 days for Hib or pneumococcus; stop for other organisms. Not routine in neonates or meningococcal sepsis.
Timing: Give dexamethasone before or with the first antibiotic dose when possible . Never delay antibiotics to obtain dexamethasone.
Mechanism: Antibiotic-induced bacterial lysis releases massive quantities of cell-wall components (endotoxin, teichoic acid, peptidoglycan) into the subarachnoid space, triggering a violent inflammatory burst driven by TNF-alpha, IL-1beta, and prostaglandins. Dexamethasone suppresses cytokine transcription and limits subarachnoid inflammation.
Evidence-Based Benefits: Randomized controlled trials in European pediatric populations demonstrate that early dexamethasone significantly reduces the incidence of severe sensorineural hearing loss in Haemophilus influenzae type b and Streptococcus pneumoniae meningitis, and reduces overall neurological sequelae.
Warning
A missed first dose does not establish absence of benefit. NICE NG240: give delayed dexamethasone promptly if less than 12 hours have elapsed; after 12 hours, seek infection-specialist advice.
Cerebrospinal Fluid (CSF) Analysis Interpretation
Parameter Normal Pediatric Range Acute Bacterial Meningitis Viral (Aseptic) Meningitis Tuberculous (TB) Meningitis Partially Treated Bacterial Meningitis
Opening Pressure 10 to 20 cm H 2 O H_2O H 2 O Markedly elevated (>20–30 cm H 2 O H_2O H 2 O ) Normal or mildly elevated Markedly elevated Normal or mildly elevated
Macroscopic Appearance Clear, colorless ("crystal clear") Turbid, cloudy, purulent Clear or slightly opalescent Clear or opalescent; fibrin "cobweb" clot on standing Clear or slightly cloudy
White Blood Cells (WBC/microL) <5 cells/microL (neonates <20) Markedly elevated: 1,000 to 10,000+ Moderately elevated: 50 to 500 (rarely >1,000) Moderately elevated: 100 to 500 Variable: 100 to 5,000
Differential >95% Lymphocytes/Monocytes Neutrophil predominance (>80–90%) Lymphocyte predominance (early neutrophils in first 12–24h) Lymphocyte predominance Neutrophil or mixed predominance
Protein Concentration 0.15 to 0.45 g/L (neonates up to 1.0) Markedly elevated (>1.0 to 5.0+ g/L) Normal or mildly elevated (0.4 to 1.0 g/L) Extremely elevated (>1.5 to 5.0+ g/L) Elevated (0.6 to 2.0 g/L)
CSF-to-Blood Glucose Ratio >0.6 (>60%) Profoundly low (<0.4 or <40%, often <0.2) Normal (>0.6 or >60%) Very low (<0.3 or <30%) Low or intermediate (0.3 to 0.5)
Gram Stain & Culture Negative Gram stain positive in 60–80% ; culture positive Negative Gram stain and bacterial culture Negative Gram stain; Acid-fast bacilli (ZN/Auramine) positive Gram stain positive in ~30–50%; culture often sterile
Molecular Diagnostics Negative Multiplex PCR positive for bacterial DNA Multiplex PCR positive (Enterovirus, HSV, VZV) PCR positive ( Mycobacterium tuberculosis GeneXpert) Multiplex bacterial PCR positive
Chemoprophylaxis for Close Contacts of Meningococcal Disease
Close contacts of patients with confirmed or suspected invasive meningococcal disease have an estimated 500- to 1,000-fold increased risk of developing disease. Chemoprophylaxis eradicates nasopharyngeal carriage of Neisseria meningitidis .
Indications for Chemoprophylaxis
All household members residing in the same dwelling.
Daycare or preschool classroom contacts within the 7 days prior to disease onset .
Anyone with direct exposure to oral secretions (e.g., kissing, mouth-to-mouth resuscitation, endotracheal intubation without face mask/eye protection).
Recommended Regimens
Oral Ciprofloxacin: Preferred first-line agent for adults and children due to single-dose convenience:
Children: Single oral dose of 20 mg/kg (maximum 500 mg).
Adults: Single oral dose of 500 mg .
Oral Rifampicin:
Children <1 month: 5 mg/kg orally every 12 hours for 2 days (4 doses total).
Children ≥1 month: 10 mg/kg orally every 12 hours for 2 days (4 doses total; max 600 mg/dose).
Counseling: Stains body secretions (urine, sweat, tears) a bright orange-red; permanently discolors soft contact lenses; potent inducer of hepatic CYP450 enzymes that reduces efficacy of oral contraceptive pills.
Intramuscular Ceftriaxone:
Children <12 years: Single IM injection of 125 mg .
Adults & Children ≥12 years: Single IM injection of 250 mg .
Drug of choice in pregnant women .
Viral Encephalitis: Herpes Simplex Virus and High-Dose Aciclovir
While viral meningitis is typically a self-limiting inflammation of the leptomeninges, viral encephalitis represents direct viral invasion and inflammation of the brain parenchyma , presenting with marked cerebral dysfunction.
Clinical Distinction: Meningitis vs. Encephalitis
Meningitis: Meningeal inflammation typically causes fever, headache, photophobia, and stiff neck. Bacterial meningitis can also cause altered consciousness, seizures, or focal deficits; these findings do not establish a viral cause.
Encephalitis: Features of parenchymal brain involvement:
Altered consciousness: Confusion, delirium, disorientation, lethargy, stupor, or coma.
Focal neurological deficits: Hemiparesis, cranial neuropathies, aphasia/dysphasia.
Seizures: Frequently focal or secondarily generalized motor seizures.
Behavioral and psychiatric disturbances: Agitation, hallucinations, bizarre behavior, personality change.
Herpes Simplex Virus Type 1 (HSV-1) Encephalitis
Pathophysiology: The most common cause of non-epidemic, sporadic, fatal viral encephalitis in children and adults. HSV-1 reaches the brain via retrograde axonal transport along the olfactory or trigeminal nerves, exhibiting an intense predilection for the temporal lobes, orbitofrontal cortex, and limbic system , causing severe hemorrhagic necrotizing encephalitis .
Clinical Presentation: Acute onset of high fever, hemicranial headache, progressive confusion, focal seizures (often temporal semiology), expressive dysphasia, memory deficits, and bizarre psychiatric manifestations.
Diagnostic Workup:
CSF Analysis: Lymphocytic pleocytosis (50 to 500 WBC/microL), elevated protein (0.6 to 1.5 g/L), normal glucose, and presence of erythrocytes (RBCs) or xanthochromia resulting from temporal lobe hemorrhagic necrosis.
Molecular Gold Standard: CSF HSV PCR (sensitivity and specificity >95%). Note: If CSF is sampled within the first 24 to 48 hours of symptoms, PCR may occasionally be false-negative. If clinical suspicion is high, continue aciclovir and repeat LP at 48 to 72 hours.
Neuroimaging (Contrast-Enhanced MRI Brain): Hyperintensity on T2-weighted and FLAIR sequences with restricted diffusion characteristically localized to the inferior and medial temporal lobes, insular cortex, and orbital surfaces of the frontal lobes (typically asymmetrical) .
Electroencephalography (EEG): Periodic Lateralized Epileptiform Discharges (PLEDs) and sharp-and-slow wave complexes over the affected temporal lobe.
Emergency Pharmacotherapy:
Important
IMMEDIATE EMPIRICAL ACICLOVIR: Initiate high-dose intravenous aciclovir immediately upon clinical suspicion. Never withhold aciclovir while awaiting PCR results or neuroimaging.
Pediatric Dosage: Young infants: 20 mg/kg IV every 8 hours ; 3 months–12 years: 500 mg/ m 2 m^2 m 2 IV every 8 hours ; above 12 years: 10 mg/kg IV every 8 hours . Adjust for renal function; infuse over 1 hour.
Duration: At least 21 days in neonates and children through 12 years ; older children generally 14–21 days . Repeat CSF HSV PCR before stopping; if still positive, continue treatment and repeat PCR weekly until negative.
Renal Protection: Aciclovir can precipitate as crystals in the renal tubules, leading to acute crystalline nephropathy. Maintain generous intravenous hydration and monitor serum creatinine regularly.
- Acute Flaccid Weakness and Peripheral Neuropathies
- Guillain–Barré Syndrome (GBS)
An immune-mediated polyradiculoneuropathy that often follows a respiratory or gastrointestinal infection, such as Campylobacter jejuni . It causes progressive, roughly symmetrical, ascending weakness with reduced or absent reflexes . Young children often present with pain, irritability or refusal to walk.
Nadir is usually reached within 4 weeks. Danger signs are respiratory failure, bulbar weakness and autonomic instability (arrhythmias and blood pressure swings), so monitor vital capacity, swallowing, heart rate and blood pressure.
Investigations : CSF typically shows raised protein with a normal cell count (albuminocytological dissociation), although it may be normal in the first week. Nerve conduction studies support the diagnosis.
Treatment : for patients who cannot walk unaided, give intravenous immunoglobulin 0.4 g/kg/day for 5 days (2 g/kg in total) within 2 weeks of onset, or plasma exchange within 4 weeks. Corticosteroids are not recommended, and a second immunoglobulin course is not recommended for a poor prognosis. Most children recover well with rehabilitation.
Miller Fisher syndrome combines ophthalmoplegia, ataxia and areflexia and is associated with anti-GQ1b antibodies.
Inherited Neuropathies
Charcot–Marie–Tooth disease is the commonest inherited neuropathy; type 1A is an autosomal dominant PMP22 duplication. It causes slowly progressive distal weakness and wasting, pes cavus, toe walking or frequent tripping and reduced reflexes, with slowed nerve conduction in demyelinating forms.
Source: EAN/PNS Guideline on diagnosis and treatment of Guillain–Barré syndrome .